The alert comes after CDSCO flagged several pharmaceutical products as Not of Standard Quality (NSQ) following failed quality control tests. The medications, sampled from various distribution and sales points across India, were manufactured by 17 pharmaceutical companies—some of which have business ties, subsidiaries, or product presence in Nigeria.
In response, NAFDAC has called on healthcare professionals, pharmacists, and consumers across Nigeria to exercise heightened vigilance when handling pharmaceutical products, especially those of Indian origin. (TVC)
